Silk fibroin microparticles as carriers for delivery of human recombinant bone morphogenetic protein-2: In vitro and in vivo bioactivity

Tissue Engineering - Part C: Methods

Volumn 16, Issue 5, 2010, Pages 937-945

  Bessa, Paulo César ^a,b   Balmayor, Elizabeth R ^a   Hartinger, Joachim ^b   Zanoni, Gerald ^b   Dopler, Daniela ^b   Meinl, Alexandra ^b,c   Banerjee, Asmita ^b   Casal, Margarida ^a   Redl, Heinz ^b   Reis, Rui L ^a   Van Griensven, Martijn ^b  

^a UNIVERSITY OF MINHO   (Portugal)

^b LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^c Bernhard Gottlieb School of Dentistry   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; CELL CULTURE; COMPUTERIZED TOMOGRAPHY; PHOSPHATASES; PROTEINS; SILK; TISSUE ENGINEERING;

ALIZARIN RED; ALKALINE PHOSPHATASE ACTIVITY; BONE FORMATION; BONE MORPHOGENETIC PROTEIN-2; BONE TISSUE ENGINEERING; C2C12 CELLS; CLINICAL APPLICATION; DOSE RESPONSE; ECTOPIC BONES; GROWTH FACTOR; IMMUNOSTAINING; IN-VITRO; IN-VIVO; MICRO-PARTICLES; OSTEOCALCIN; POST-IMPLANTATION; PROCESSING METHOD; RECOMBINANT BONE MORPHOGENETIC PROTEIN-2; SILK FIBROIN;

BONE;

RATTUS;

BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; DRUG CARRIER; FIBROIN; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BONE DEVELOPMENT; CELL LINE; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IN VITRO STUDY; MALE; RAT; SILK; SPRAGUE DAWLEY RAT;

ANIMALS; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEIN 2; CELL LINE; DRUG CARRIERS; FIBROINS; HUMANS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SILK; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77957372082     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2009.0486     Document Type: Article

References (47)

1. Reddi, A.H. BMPs: from bone morphogenetic proteins to body morphogenetic proteins. Cytokine Growth Factor Rev 16, 249, 2005.
2. Bessa, P.C., Casal, M., and Reis, R.L. Bone morphogenetic proteins in tissue engineering: the road from laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2, 1, 2008.
3. Bessa, P.C., Casal, M., and Reis, R.L. Bone morphogenetic proteins in tissue engineering: the road from laboratory to the clinic, part II (BMP delivery). J Tissue Eng Regen Med 2, 81, 2008.
4. Gautschi, O.P., Frey, S.P., and Zellweger, R. Bone morphogenetic proteins in clinical applications. ANZ J Surg 77, 626, 2007.
5. Kim, K., and Fisher, J.P. Nanoparticle technology in bone tissue engineering. J Drug Target 15, 241, 2007.
6. Mano, J.F., Silva, G.A., Azevedo, H.S., Malafaya, P.B., Sousa, R.A., Silva, S.S., Boesel, L.F., Oliveira, J.M., Santos, T.C., Marques, A.P., Neves, N.M., and Reis, R.L. Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends. J Royal Soc Interface 4, 999, 2007.
7. Karageorgiou, V., Meinel, L., Hofmann, S., Malhotra, A., Volloch, V., and Kaplan, D. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J Biomed Mater Res A 71, 528, 2004.
8. Karageorgiou, V., Tomkins, M., Fajardo, R., Meinel, L., Snyder, B., Wade, K., Chen, J., Vunjak-Novakovic, G., and Kaplan, D.L. Porous silk fibroin 3D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J Biomed Mater Res A 78, 324, 2006.
9. Li, C., Vepari, C., Jin, H.J., Kim, H.J., and Kaplan, D.L. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 27, 3115, 2006.
10. Kirker-Head, C., Karageorgiou, V., Hofmann, S., Fajardo, R., Betz, O., Merkle, H.P., Hilbe, M., von Rechenberg, B., McCool, J., Abrahamsen, L., Nazarian, A., Cory, E., Curtis, M., Kaplan, D., and Meinel, L. BMP-silk composite matrices heal critically sized femoral defects. Bone 41, 247, 2007.
11. Nam, J., and Park, Y.H. Morphology of regenerated silk fibroin: effects of freezing temperature, alcohol addition, and molecular weight. J Appl Polym Sci 81, 3008, 2001.
12. Zhang, Y.Q., Shen, W.D., Xiang, R.L., Zhuge, L.J., Gao, W.J., and Wang, W.B. Formation of silk fibroin nanoparticles in water-miscible organic solvent and their characterization. J Nanoparticle Res 9, 885, 2007.
13. Cao, Z., Chen, X., Yao, J., Huang, L., and Shao, Z. The preparation of regenerated silk fibroin microspheres. Soft Matter 3, 910, 2007.
14. Bessa, P.C., Balmayor, E.R., Azevedo, H.S., Nü rberger, S., Casal, M., van Griensven, M., Reis, R.L., and Redl, H. Silk fibroin microparticles as carriers for delivery of human recombinant BMPs. Physical characterization and drug release. J Tissue Eng Regen Med 2009 (In press).
15. Klö sch, B., Fü rst, W., Kneidinger, R., Schuller, M., Rupp, B., Banerjee, A., and Redl, H. Expression and purification of biologically active rat bone morphogenetic protein-4 produced as inclusion bodies in recombinant Escherichia coli. Biotechnol Lett 27, 1559, 2005.
16. Long, S., Truong, L., Bennett, K., Phillips, A., Wong-Stall, F., and Ma, H. Expression, purification, and renaturation of bone morphogenetic protein-2 from Escherichia coli. Protein Expr Purif 46, 374, 2006.
17. Bessa, P.C., Pedro, A.J., Klosch, B., Nobre, A., van Griensven, M., Reis, R.L., and Casal, M. Osteoinduction in human fat-derived stem cells by recombinant human bone morphogenetic protein-2 produced in Escherichia coli. Biotechnol Lett 30, 15, 2008.
18. Bessa, P.C., Cerqueira, M.T., Rada, T., Gomes, M.E., Neves, N.M., Nobrc, A., Reis, R.L., and Casal, M. Expression, purification and osteogenic bioactivity of recombinant human BMP-4,-9,-10,-11 and-14. Protein Expr Purif 63, 89, 2009.
19. Katagiri, T., Yamaguchi, A., Komaki, M., Abe, E., Takahashi, N., Ikeda, T., Roscn, V., Wozney, J.M., Fujisawa-Sehara, A., and Suda, T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteogenic lineage. J Cell Biol 127, 1755, 1994.
20. Salgado, A.J., Gomes, M.E., Chou, A., Coutinho, O.P., Reis, R.L., and Hutmacher, D.W. Preliminary study on the adhesion and proliferation of human osteoblasts on starch-based scaffolds. Mater Sci Eng 20, 27, 2002.
21. Gregory, C.A., Gunn, W.G., Peister, A., and Prockop, D.J. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 329, 77, 2004.
22. Seeherman, H., and Wozney, J.M. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 16, 329, 2005.
23. Lammel, A., Schwab, M., Slotta, U., Winter, G., and Scheibel, T. Processing conditions for the formation of spider silk microspheres. Chem Sus Chem 1, 413, 2008.
24. Vallejo, L.F., Brokelmann, M., Marten, S., Trappe, S., Cabrera-Crespo, J., Hoffmann, A., Gross, G., Weich, H.A., and Rinas, U. Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli. J Biotechnol 94, 185, 2002.
25. Wang, X., Wenk, E., Matsumoto, A., Meinel, L., Li, C., and Kaplan, D.L. Silk microspheres for encapsulation and controlled release. J Control Release 117, 360, 2007.
26. Wenk, E., Wandrey, A.J., Merkle, H.P., and Meinel, L. Silk fibroin spheres as a platform for controlled drug delivery. J Control Release 132, 26, 2008.
27. Altman, G.H., Diaz, F., Jakuba, C., Calabro, T., Horan, R.L., Chen, J., Lu, H., Richmond, J., and Kaplan, D.L. Silk-based biomaterials. Biomaterials 24, 401, 2003.
28. Meinel, L., Hofmann, S., Karageorgiou, V., Kirker-Head, C., McCool, J., Gronowicz, G., Zichner, L., Langer, R., Vunjak-Novakovic, G., and Kaplan, D.L. The inflammatory responses to silk films in vitro and in vivo. Biomaterials 26, 147, 2005.
29. Wang, Y., Rudym, D.D., Walsh, A., Abrahamsen, L., Kim, H.J., Kim, H.S., Kirker-Head, C., and Kaplan, D.L. In vivo degradation of three-dimensional silk fibroin scaffolds. Biomaterials 29, 3415, 2008.
30. Bulpitt, P., and Aeschlimann, D. New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J Biomed Mater Res 47, 152, 1999.
31. Maire, M., Chaubet, F., Mary, P., Blanchat, C., Meunier, A., and Logeart-Avramoglou, D. Bovine BMP osteoinductive potential enhanced by functionalized dextran-derived hydrogels. Biomaterials 26, 5085, 2005.
32. Zhang, C., Hu, Y., Xiong, Z., Zhang, S., Yan, Y., and Cui, F. [Tissue engineered bone regeneration of periosteal cells us-ing recombinant human bone morphogenetic protein 2 induce]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 19, 100, 2005.
33. Kato, M., Namikawa, T., Terai, H., Hoshino, M., Miyamoto, S., and Takaoka, K. Ectopic bone formation in mice associated with a lactic acid=dioxanone=ethylene glycol copolymer-tricalcium phosphate composite with added recombinant human bone morphogenetic protein-2. Biomaterials 27, 3927, 2006.
34. Jeon, O., Song, S.J., Kang, S.W., Putnam, A.J., and Kim, B.S. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly (L-lactic-co-glycolic acid) scaffold. Biomaterials 28, 2763, 2007.
35. Hangartnen, T.N. Thresholding technique for accurate analysis of density and geometry in QCT, pQCT and microCT images. J Musculoskelet Neuronal Interact 7, 9, 2007.
36. Cowan, C., Aghaloo, T., Chou, Y.-F., Walder, B., Zhang, X., Soo, C., Ting, K., and Wu, B. MicroCT evaluation of threedimensional mineralization in response to BMP-2 doses in vitro and in critical size rat calvarial defects. Tissue Eng 13, 501, 2007.
37. Price, P.A. Gla-containing proteins of bone. Connect Tissue Res 21, 51, 1989.
38. Cunningham, N.S., Paralkar, V., and Reddi, A.H. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci USA 89, 11740, 1992.
39. Louis-Ugbo, J., Kim, H.S., Boden, S.D., Mary, M.T., Li, R.C., Seeherman, H., D'Augusta, D., Blake, C., Jiao, A., and Peckham, S. Retention of 125I-labeled recombinant human bone morphogenetic protein-2 by biphasic calcium phosphate or a composite sponge in a rabbit posterolateral spine arthrodesis model. J Orthop Res 20, 1050, 2002.
40. Wei, G., Jin, Q., Giannobile, W.V., and Ma, P.X. The enhancement of osteogenesis by nanofibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 28, 2087, 2007.
41. Bentz, H., Schroeder, J.A., and Estridge, T.D. Improved local delivery of TGF-b2 by binding to injectable fibrillar collagen via difunctional polyethylene glycol. J Biomed Mater Res 39, 539, 1998.
42. Uludag, H., D'Augusta, D., Palmer, R., Timony, G., and Wozney, J. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J Biomed Mater Res 46, 193, 1999.
43. Uludag, H., D'Augusta, D., Golden, J., Li, J., Timony, G., Riedel, G., and Wozney, J.M. Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: a correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model. J Biomed Mater Res 50, 227, 2000.
44. Kenley, R., Marden, L., Turek, T., Jin, L., Ron, E., and Hollinger, J.O. Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). J Biomed Mater Res 28, 1139, 1994.
45. Hosseinkhani, H., Hosseinkhani, M., Khademhosseini, A., and Kobayashi, H. Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold. J Control Release 117, 380, 2007.
46. Meinel, L., Betz, O., and Fajardo, R. Silk based biomaterials to heal critical sized femur defects. Bone 39, 922, 2006.
47. Yilgor, P., Tuzlakoglu, K., Reis, R.L., Hasirci, N., and Hasirci, V. Incorporation of a sequential BMP-2=BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Biomaterials 30, 3551, 2009.